pubmed-article:9183334 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:9183334 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:9183334 | lifeskim:mentions | umls-concept:C0473169 | lld:lifeskim |
pubmed-article:9183334 | lifeskim:mentions | umls-concept:C0032143 | lld:lifeskim |
pubmed-article:9183334 | lifeskim:mentions | umls-concept:C0155626 | lld:lifeskim |
pubmed-article:9183334 | lifeskim:mentions | umls-concept:C0007785 | lld:lifeskim |
pubmed-article:9183334 | lifeskim:mentions | umls-concept:C0019134 | lld:lifeskim |
pubmed-article:9183334 | lifeskim:mentions | umls-concept:C0475224 | lld:lifeskim |
pubmed-article:9183334 | lifeskim:mentions | umls-concept:C0596545 | lld:lifeskim |
pubmed-article:9183334 | lifeskim:mentions | umls-concept:C0206034 | lld:lifeskim |
pubmed-article:9183334 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
pubmed-article:9183334 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:9183334 | pubmed:dateCreated | 1997-7-1 | lld:pubmed |
pubmed-article:9183334 | pubmed:abstractText | Ischemic cerebral infarction (CI) is a serious complication of acute myocardial infarction (MI). Little information exists on CI after thrombolytic therapy for MI. | lld:pubmed |
pubmed-article:9183334 | pubmed:language | eng | lld:pubmed |
pubmed-article:9183334 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9183334 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:9183334 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9183334 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9183334 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9183334 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:9183334 | pubmed:month | Jun | lld:pubmed |
pubmed-article:9183334 | pubmed:issn | 0039-2499 | lld:pubmed |
pubmed-article:9183334 | pubmed:author | pubmed-author:BraunwaldEE | lld:pubmed |
pubmed-article:9183334 | pubmed:author | pubmed-author:HodgesMM | lld:pubmed |
pubmed-article:9183334 | pubmed:author | pubmed-author:MuellerHH | lld:pubmed |
pubmed-article:9183334 | pubmed:author | pubmed-author:GoreJ MJM | lld:pubmed |
pubmed-article:9183334 | pubmed:author | pubmed-author:RogersW JWJ | lld:pubmed |
pubmed-article:9183334 | pubmed:author | pubmed-author:ChaitmanB RBR | lld:pubmed |
pubmed-article:9183334 | pubmed:author | pubmed-author:KnatterudG... | lld:pubmed |
pubmed-article:9183334 | pubmed:author | pubmed-author:FormanSS | lld:pubmed |
pubmed-article:9183334 | pubmed:author | pubmed-author:PriceT RTR | lld:pubmed |
pubmed-article:9183334 | pubmed:author | pubmed-author:SloanM AMA | lld:pubmed |
pubmed-article:9183334 | pubmed:author | pubmed-author:TerrinM LML | lld:pubmed |
pubmed-article:9183334 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:9183334 | pubmed:volume | 28 | lld:pubmed |
pubmed-article:9183334 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:9183334 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:9183334 | pubmed:pagination | 1107-14 | lld:pubmed |
pubmed-article:9183334 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:9183334 | pubmed:meshHeading | pubmed-meshheading:9183334-... | lld:pubmed |
pubmed-article:9183334 | pubmed:meshHeading | pubmed-meshheading:9183334-... | lld:pubmed |
pubmed-article:9183334 | pubmed:meshHeading | pubmed-meshheading:9183334-... | lld:pubmed |
pubmed-article:9183334 | pubmed:meshHeading | pubmed-meshheading:9183334-... | lld:pubmed |
pubmed-article:9183334 | pubmed:meshHeading | pubmed-meshheading:9183334-... | lld:pubmed |
pubmed-article:9183334 | pubmed:meshHeading | pubmed-meshheading:9183334-... | lld:pubmed |
pubmed-article:9183334 | pubmed:meshHeading | pubmed-meshheading:9183334-... | lld:pubmed |
pubmed-article:9183334 | pubmed:meshHeading | pubmed-meshheading:9183334-... | lld:pubmed |
pubmed-article:9183334 | pubmed:meshHeading | pubmed-meshheading:9183334-... | lld:pubmed |
pubmed-article:9183334 | pubmed:meshHeading | pubmed-meshheading:9183334-... | lld:pubmed |
pubmed-article:9183334 | pubmed:meshHeading | pubmed-meshheading:9183334-... | lld:pubmed |
pubmed-article:9183334 | pubmed:meshHeading | pubmed-meshheading:9183334-... | lld:pubmed |
pubmed-article:9183334 | pubmed:meshHeading | pubmed-meshheading:9183334-... | lld:pubmed |
pubmed-article:9183334 | pubmed:meshHeading | pubmed-meshheading:9183334-... | lld:pubmed |
pubmed-article:9183334 | pubmed:meshHeading | pubmed-meshheading:9183334-... | lld:pubmed |
pubmed-article:9183334 | pubmed:year | 1997 | lld:pubmed |
pubmed-article:9183334 | pubmed:articleTitle | Ischemic cerebral infarction after rt-PA and heparin therapy for acute myocardial infarction. The TIMI-II pilot and randomized clinical trial combined experience. | lld:pubmed |
pubmed-article:9183334 | pubmed:affiliation | Maryland Medical Research Institute, Baltimore 21210, USA. | lld:pubmed |
pubmed-article:9183334 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:9183334 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:9183334 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:9183334 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9183334 | lld:pubmed |